Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis

Published:2017-02-23 Issue:4 Volume:119 Page:515-521
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Abo Youssef Nadim¹,Schneider Marc P.¹²³,Mordasini Livio⁴,Ineichen Benjamin V.²³,Bachmann Lucas M.⁵,Chartier-Kastler Emmanuel⁶,Panicker Jalesh N.⁷,Kessler Thomas M.¹

Affiliation:

1. Neuro-Urology, Spinal Cord Injury Center and Research; Balgrist University Hospital; University of Zürich; Zürich Switzerland

2. Brain Research Institute; University of Zürich; Zürich Switzerland

3. Department of Health Sciences and Technology; Swiss Federal Institute of Technology Zürich; Zürich Switzerland

4. Department of Urology; Cantonal Hospital Lucerne; Lucerne Switzerland

5. Medignition Inc., Research Consultants; Zürich Switzerland

6. Department of Urology; Academic Hospital Pitié-Salpêtrière; Assistance Publique-Hôpitaux de Paris; Pierre et Marie Curie Medical School; Sorbonne Universités; Paris 6 University; Paris France

7. Department of Uro-Neurology; National Hospital for Neurology and Neurosurgery and UCL Institute of Neurology; London UK

Funder

Swiss Continence Foundation

UK's Department of Health National Institute of Health Research Biomedical Research Centres

Schweizerische Akademie der Medizinischen Wissenschaften

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13759/fullpdf

Reference24 articles.